Abstract
The development of pancreatic cancer (PC) may involve the over-expression of oncogenes, inactivation tumor suppressor genes or the deregulation of various signaling proteins. Thus identification and analysis of transcriptional regulatory relationship as well as protein–protein interaction (PPI) in PC to provide deep insights into the pathogenetic mechanism of pancreatic cancer. In this study, we downloaded the gene expression profile of PC from Gene Expression Omnibus and identified differentially expressed genes (DEGs) in PC patients compared with controls. To further understand how these DEGs act together to account for the initiation of pancreatic cancer, a transcriptional regulatory network was constructed to find the notes for GO function and KEGG pathways annotation, aiming to explore the clusters and pathways in PC. A total of 1,821 transcriptional regulatory relationships were identified. Then, a PPI network was constructed and noted by GO and KEGG, and some special modules, clusters and pathways were identified to involved in PC. Finally, we constructed the transcriptional regulatory network and PPI network of pancreatic cancer. Comparing the pathways involved in Transcriptional regulatory network and PPI network, pathway in cancer, PC, p53 signaling pathway, Hematopoietic cell lineage and graft-versus-host disease co-existed in these two network, so we predict these pathways may play key factors in development of cancer.
Similar content being viewed by others
Abbreviations
- PC:
-
Pancreatic cancer
- KEGG:
-
Kyoto encyclopedia of genes and genomes
- HPRD:
-
Human protein reference database
- PPI:
-
Protein–protein interaction
- TF:
-
Transcriptional factors
References
Hruban RH, Brune K, Fukushima N, Maitra A (2008) Pancreatic intraepithelial neoplasia. Pancreatic Cancer:41–51
Sato N, Goggins M (2006) The role of epigenetic alterations in pancreatic cancer. J Hepato-Biliary-Pancreatic Surg 13(4):286–295
Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L (1993) Pancreatitis and the risk of pancreatic cancer. New Engl J Med 328(20):1433–1437
Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Sci’s STKE 321(5897):1801
Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB (2007) Population-based study of islet cell carcinoma. Annals Surg Oncol 14(12):3492–3500
Maitra A, Kern SE, Hruban RH (2006) Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):211–226
Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030
Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358(6381):15
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Signer SH, Davidson N, Baylin S, Devilee P (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342(6250):705–708
Barbacid M (1987) Ras genes. Annual Rev Biochem 56(1):779–827
Pan J, Roskelley CD, Rojiani M, Auersperg N (1992) Reversal of divergent differentiation by ras oncogene-mediated transformation. Cancer Res 52(15):4269
Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD (1992) Identification of heregulin, a specific activator of p185erbB2. Science 256(5060):1205–1210
Bell S, Scott N, Cross D, Sagar P, Lewis F, Blair G, Taylor G, Dixon M, Quirke P (1993) Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 104(1):57
Song Y, Washington MK, Crawford HC (2010) Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 70(5):2115–2125
Dong C, Wilhelm D, Koopman P (2004) Sox genes and cancer. Cytogenet Genome Res 105(2–4):442–447
Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K (2004) Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64(6):2030–2038
Zhao X-M, Wang R-S, Chen L, Aihara K (2008) Uncovering signal transduction networks from high-throughput data by integer linear programming. Nucleic Acids Res 36(9):e48–e48
Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18(4):644–652
Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16(3):259–266
Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55(88):2016–2027
Matys V, Fricke E, Geffers R, Goessling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV (2003) TRANSFAC®: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31(1):374–378
Sandelin A, Alkema W, Engström P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32(Suppl 1):D91–D94
Prasad TSK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A (2009) Human protein reference database—2009 update. Nucleic Acids Res 37(Suppl 1):D767–D772
Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (1999) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27(1):29–34
Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56(8):1134–1152
Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363(9414):1049–1057
Pusch C, Hustert E, Pfeifer D, Südbeck P, Kist R, Roe B, Wang Z, Balling R, Blin N, Scherer G (1998) The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum Genet 103(2):115–123
Southard-Smith EM, Kos L, Pavan WJ (1998) Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet 18(1):60–64
Kadonaga JT, Carner KR, Masiarz FR, Tjian R (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51(6):1079
Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R (1990) Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. The EMBOJ 9(11):3631
Carey M, Smale ST (2001) Transcriptional regulation in eukaryotes: concepts, strategies, and techniques. Cold Spring Harbor Laboratory Pr, New York
Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S (2005) A human protein–protein interaction network: a resource for annotating the proteome. Cell 122(6):957–968
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
The procedures in this study were approved by the Chinese Ethics Committee of Human Experimentation.
Rights and permissions
About this article
Cite this article
Sun, H., Han, B., Cheng, X. et al. Transcriptional regulatory network and protein–protein interaction to reveal the mechanism of pancreatic cancer. Mol Biol Rep 41, 387–395 (2014). https://doi.org/10.1007/s11033-013-2872-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-013-2872-0